The treatment results of malignant Non-Hodgkin\u2019s Lymphomas with CHOP regiment at the Military Hospital No 108
- Author:
Truong Van Le
;
Chinh Trung Nguyen
- Publication Type:Journal Article
- Keywords:
malignant Non-Hodgkin\u2019s Lymphomas;
CHOP regiment
- MeSH:
malignant Non-Hodgkin\u2019s Lymphomas;
CHOP regiment
- From:Journal of Medical and Pharmaceutical Information
2003;0(5):27-30
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
Background: Malignant Non-Hodgkin's Lymphomas is one of the ten most common malignant diseases. Until recently, Chop regimen is considered as the standard treatment regimen for Non-Hodgkin's Lymphomas of intermediate and high grade.\r\n", u'Objectives: Assessing response rates, side effects, survival time and in treatment for these patients with CHOP regimen.\r\n', u'Subjects and methods: The controlled, prospective, descriptive study was carried out on 40 patients with Non-Hodgkin\u2019s Lymphomas of intermediate and high grade treated at the Military Hospital No 108.\r\n', u'Results and conclusion: The prevalence in men was higher than in women (77.5% compared to 22.5%). Complete remission accounts for 70%, part remission 15%, stable state of disease 5%, progressive disease 10%. Overall survival of 5 years is estimated at 37.23% disease-free survival of 5 years at 34.04%, event-free survival of 5 years at 32.46%, progressive-free survival of 5 years at 29.93%. There was a total of 241 chemical transmitted turns. Common side effects were nausea, vomiting, mouth ulcers, diarrhea and hair loss. This result was consistent with the results of previous studies.\r\n', u'
